<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS One</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title-group><journal-title>PLOS One</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40397898</article-id><article-id pub-id-type="pmc">PMC12094766</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0324366</article-id><article-id pub-id-type="publisher-id">PONE-D-25-04521</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Cognitive Science</subject><subj-group><subject>Cognitive Psychology</subject><subj-group><subject>Perception</subject><subj-group><subject>Sensory Perception</subject><subj-group><subject>Vision</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Psychology</subject><subj-group><subject>Cognitive Psychology</subject><subj-group><subject>Perception</subject><subj-group><subject>Sensory Perception</subject><subj-group><subject>Vision</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social Sciences</subject><subj-group><subject>Psychology</subject><subj-group><subject>Cognitive Psychology</subject><subj-group><subject>Perception</subject><subj-group><subject>Sensory Perception</subject><subj-group><subject>Vision</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Neuroscience</subject><subj-group><subject>Sensory Perception</subject><subj-group><subject>Vision</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Population Groupings</subject><subj-group><subject>Age Groups</subject><subj-group><subject>Children</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Population Groupings</subject><subj-group><subject>Families</subject><subj-group><subject>Children</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Clinical Genetics</subject><subj-group><subject>Chromosomal Disorders</subject><subj-group><subject>Down Syndrome</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Ophthalmology</subject><subj-group><subject>Visual Impairments</subject><subj-group><subject>Myopia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular System</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular System</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Eye Diseases</subject><subj-group><subject>Lens Disorders</subject><subj-group><subject>Cataracts</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Ophthalmology</subject><subj-group><subject>Eye Diseases</subject><subj-group><subject>Lens Disorders</subject><subj-group><subject>Cataracts</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Ophthalmology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Health Care</subject><subj-group><subject>Health Care Policy</subject><subj-group><subject>Screening Guidelines</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Prevalence of ophthalmic abnormalities and refractive changes in Taiwanese children with Down syndrome</article-title><alt-title alt-title-type="running-head">Ophthalmic findings and refractive changes in children with Down syndrome</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Chia-Ping</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role><role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="aff001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tsai</surname><given-names>Tzu-Hsun</given-names></name><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yao-Lin</given-names></name><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5011-7499</contrib-id><name><surname>Lee</surname><given-names>Ni-Chung</given-names></name><role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff004" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0504-8535</contrib-id><name><surname>Yang</surname><given-names>Che-Ning</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="aff006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5766-3057</contrib-id><name><surname>Lin</surname><given-names>Chao-Wen</given-names></name><role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role><role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role><role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role><role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role><role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role><role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="aff002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Medical Education, National Taiwan University Hospital, Taipei, Taiwan</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Ophthalmology, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>School of Medicine, National Taiwan University, Taipei, Taiwan.</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Bayoumi</surname><given-names>Nader Hussien Lotfy</given-names></name><role>Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">
<addr-line>Alexandria University Faculty of Medicine, EGYPT</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>b91401108@ntu.edu.tw</email></corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>20</volume><issue>5</issue><elocation-id>e0324366</elocation-id><history><date date-type="received"><day>1</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>24</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 Chen et al</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Chen et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0324366.pdf">
</self-uri><abstract><sec id="sec001"><title>Background</title><p>Ophthalmological manifestations in children with Down syndrome remain significantly underdiagnosed, particularly in Asian populations. This study aimed to investigate the prevalence and characteristics of ophthalmic disorders in Taiwanese children with Down syndrome, analyze their refractive changes over time, and compare findings with existing research across diverse ethnic populations.</p></sec><sec id="sec002"><title>Methods</title><p>Comprehensive ophthalmologic examinations were conducted on 148 Taiwanese children with Down syndrome, documenting age, sex, medical history, ocular alignment, visual acuity, and cycloplegic refraction. Annual refractive change assessments were performed using multivariate linear regression analysis for subjects with minimum one-year follow-up.</p></sec><sec id="sec003"><title>Results</title><p>Visually significant refractive errors were identified in 75.7% of subjects, with astigmatism being most prevalent (70.3%), followed by hyperopia (31.8%) and myopia (19.6%). Our cohort showed higher astigmatism prevalence compared to previous studies of Asian children with Down syndrome. Longitudinal analysis revealed an annual refractive change of &#x02212;0.16&#x02009;&#x000b1;&#x02009;0.65 diopters, with age and baseline spherical equivalence emerging as significant contributing factors.</p></sec><sec id="sec004"><title>Conclusions</title><p>This study provides unprecedented data on ophthalmic disorders and refractive changes in Taiwanese children with Down syndrome. The high prevalence of refractive errors, particularly astigmatism, underscores the importance of early and regular screening in this population. These findings may inform the development of targeted screening protocols and optimal intervention timing.</p></sec></abstract><funding-group><funding-statement>The author(s) received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="4"/><page-count count="12"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec005"><title>1. Introduction</title><p>Down syndrome (DS) is a significant chromosomal disorder affecting approximately 1 in 1,000 live births globally [<xref rid="pone.0324366.ref001" ref-type="bibr">1</xref>], though Taiwan reports a notably lower incidence of 7.9 per 10,000 live births annually due to comprehensive prenatal screening programs [<xref rid="pone.0324366.ref002" ref-type="bibr">2</xref>]. This genetic condition, caused by meiotic nondisjunction resulting in an additional copy of chromosome 21, manifests through extensive multisystemic complications including neurological, musculoskeletal, and cardiovascular abnormalities [<xref rid="pone.0324366.ref003" ref-type="bibr">3</xref>].</p><p>Visual problems represent a particularly significant concern, affecting 60% to 80% of individuals with DS [<xref rid="pone.0324366.ref004" ref-type="bibr">4</xref>]. The spectrum of ophthalmic manifestations encompasses eyelid abnormalities, refractive errors, strabismus, nystagmus, cataract, amblyopia, nasolacrimal duct obstruction, glaucoma, and keratoconus [<xref rid="pone.0324366.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0324366.ref005" ref-type="bibr">5</xref>&#x02013;<xref rid="pone.0324366.ref007" ref-type="bibr">7</xref>], as previous research focused on DS individuals from Asia, Africa, Americas and Europe. Individuals with DS exhibited a markedly higher prevalence of refractive errors compared to the general population, while whether hyperopia [<xref rid="pone.0324366.ref008" ref-type="bibr">8</xref>&#x02013;<xref rid="pone.0324366.ref011" ref-type="bibr">11</xref>] or myopia [<xref rid="pone.0324366.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0324366.ref012" ref-type="bibr">12</xref>] as the predominant refractive error was still in debate. In non-selected DS children, the prevalence of strabismus varied widely from 5.6% to 65.0% [<xref rid="pone.0324366.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0324366.ref013" ref-type="bibr">13</xref>]. Esotropia was the most common type among strabismus in children with DS and usually occurred around age three to six years old, which was older than the time of acquired esotropia developed in typically developing children around the age of two [<xref rid="pone.0324366.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0324366.ref015" ref-type="bibr">15</xref>]. A combination of factors, including reduced fusional capacity, diminished visual resolution capacity, and an insufficient accommodative convergence may contribute to the development of strabismus in children with DS [<xref rid="pone.0324366.ref007" ref-type="bibr">7</xref>].</p><p>However, some ocular disorders, such as cataracts, refractive errors and keratoconus, typically manifest during later childhood or adolescence, while early identification and correction of these conditions, can substantially enhance visual function and quality of life. Therefore, the significance of systematic monitoring is underscored by the temporal patterns of certain ocular conditions in DS children.</p><p>Amblyopia meets the World Health Organization&#x02019;s criteria for a condition that benefits from screening. It is a significant health concern with an established treatment, and reliable diagnostic methods are available to detect the condition before permanent vision loss occurs. According to the American Academy of Ophthalmology (AAO) Preferred Practice Patterns [<xref rid="pone.0324366.ref016" ref-type="bibr">16</xref>], early detection and intervention are essential during critical periods of visual development, with screening approaches tailored to each child&#x02019;s developmental stage. For infants, evaluation consists of red reflex test, fixation and following assessment, and external inspection. As children reach ages three to four years, standardized visual acuity testing with validated optotypes such as Snellen chart, Tumbling E chart, LEA symbols becomes appropriate. However, children with DS frequently experience developmental delays that limit cooperation with traditional visual acuity testing methods. For these children, instrument-based screening technologies, including photoscreening, retinoscopy, and autorefraction, are particularly valuable for detecting significant refractive errors during early childhood when conventional testing remains challenging. These objective assessment methods enable clinicians to identify visually significant refractive errors requiring correction, thereby potentially reducing amblyopia occurrence in this vulnerable population who demonstrate higher prevalence of vision abnormalities. The timely prescription of appropriate optical correction based on these evaluations represents a critical intervention for optimizing visual outcomes in children with DS.</p><p>Our study investigated and analyzed the prevalence of ophthalmic abnormalities among Taiwanese children with DS under 18 years of age. The research objectives are twofold: first, to conduct a comparative analysis of our findings against published studies examining DS children across various ethnicities and countries; and second, to evaluate refractive changes in DS children longitudinally during the follow-up period. We aimed to calculate the annual refractive progression and paid particular attention to the influence of both demographic and ophthalmological factors on these changes.</p></sec><sec sec-type="materials|methods" id="sec006"><title>2. Materials and methods</title><sec id="sec007"><title>2.1. Subjects and study design</title><p>Subjects with DS who were younger than 18 years at the time of their first ophthalmological examination at the special clinic between 2014 and 2022 were included in the study. Individuals were excluded if they were older than 18 years or had incomplete ophthalmological examination records. All ophthalmic examinations were carried out in a dedicated clinical environment following established diagnostic protocols. Subjects data, including their age, sex, medical history, ocular motility and alignment assessed using the Hirschberg test or prism cover test, visual acuity assessed using the Tumbling E chart, and cycloplegic refraction status, were collected. For DS children who were unable to demonstrate directional awareness with finger pointing when tested with Tumbling E chart, we opted for LEA symbols chart as substitute. During ocular motility and alignment assessment, we used TV programs to attract their attention and employed objects of interest to the children to maintain their focus.</p><p>Cycloplegic refraction involved administering three consecutive drops of 0.5% tropicamide at five-minute intervals. Refraction was then performed using either an autorefractor or retinoscope 30 minutes after the last tropicamide instillation. DS children were guided to focus on the house-configured fixation stimulus presented by the autorefractor through verbal cues provided by our optometrists. For DS children who remained unable to maintain adequate fixation with the autorefractor, we also used TV programs to attract their attention and employed retinoscopy as an alternative method for obtaining accurate refractive measurements. All significant ophthalmic findings were recorded. The study adhered to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board of National Taiwan University Hospital (202206019RINB). The data were accessed retrospectively from November, 2022 to May, 2023. Although the authors had access to information that could identify individual participants during data collection, we replaced medical record numbers with unique codes and ensured that no identifiable information was included in the recorded data. The mapping table linking the codes to medical record numbers was encrypted and stored separately. The Institutional Review Board approved the use of retrospective medical records without obtaining informed consent.</p><p>To assess the prevalence of ophthalmic abnormalities at various developmental stages, these DS children were classified into three age subgroups: younger or equal to six years old, over six to 12 years old, and over 12&#x02013;18 years old, expressed as early childhood, middle childhood and adolescence. For the analysis of annual refractive change, we considered children with DS with complete refraction data who had undergone regular follow-up for at least one year after their initial visit. The changes in refractive errors were expressed as spherical equivalence in diopters (D). Annual refractive changes were calculated by dividing the change in spherical equivalence by the number of years of follow-up.</p></sec><sec id="sec008"><title>2.2. Definition of refractive errors and visually significant refractive errors</title><p>Myopia was defined as spherical equivalence of &#x02212;0.5 D or less. Hyperopia was defined as spherical equivalence of 0.5 D or more. On the other hand, the definition of visually significant refractive errors varied across age groups (<xref rid="pone.0324366.s001" ref-type="supplementary-material">S1 Table</xref>). For children younger than four years, we referred to the <italic toggle="yes">Pediatric Eye Evaluations Preferred Practice Pattern</italic> published by the AAO in 2018 [<xref rid="pone.0324366.ref016" ref-type="bibr">16</xref>]. For children older than four years old, we applied the uniform definitions from 2013 version of American Association for Pediatric Ophthalmology and Strabismus (AAPOS) <italic toggle="yes">Vision Screening Committee Guidelines</italic> [<xref rid="pone.0324366.ref017" ref-type="bibr">17</xref>]. The guideline established age-stratified thresholds across five developmental categories: younger than one year, one to two years, two to three years, three to four years, and older than four years. Threshold values demonstrate an inverse relationship with advancing age: myopia thresholds range from &#x0003e; 5.0 D in infants to &#x0003e; 1.5 D in children exceeding four years of age; hyperopia without deviation ranges from &#x0003e; 6.0 D to &#x0003e; 3.5 D; hyperopia with esotropia ranges from &#x0003e; 2.0 D to &#x0003e; 1.5 D; and astigmatism ranges from &#x0003e; 3.0 D to &#x0003e; 1.5 D in cylindrical power. For anisometropia, distinct thresholds were applied for myopic, hyperopic, and astigmatic interocular differences, all following a similar age-dependent progression with diminishing thresholds correlating with increasing age.</p></sec><sec id="sec009"><title>2.3. Statistical analysis</title><p>The results are expressed as means&#x02009;&#x000b1;&#x02009;standard deviations. To compare the prevalence of ophthalmic findings in various age subgroups, the Fisher&#x02013;Freeman&#x02013;Halton exact test was employed. One-way analysis of variance with a Bonferroni post hoc test was employed to compare the annual refractive changes across age subgroups. A multivariate linear regression model was used to investigate the factors associated with refractive changes. <italic toggle="yes">P</italic> values less than 0.05 were considered significant. STATA, version 14 (Stata, College Station, TX, USA), was used for all statistical analyses.</p></sec></sec><sec sec-type="results" id="sec010"><title>3. Results</title><sec id="sec011"><title>3.1. Prevalence of ophthalmic abnormalities in children with DS</title><p>A total of 148 children (82 boys and 66 girls) were included in the study, with a mean age at their first visit of 64.9&#x02009;&#x000b1;&#x02009;56.2 months. The subgroups of early childhood, middle childhood and adolescence comprised 101, 27, and 20 children, respectively. Ophthalmic abnormalities were observed in 132 children (89.2%). Refractive errors were the most common findings, with 31 children (20.9%) having myopia (spherical equivalence&#x02009;&#x02264; &#x02212;0.5 D), and 82 (55.4%) having hyperopia (spherical equivalence&#x02009;&#x02265;&#x02009;0.5 D). In addition, 112 children (75.7%) were given a diagnosis of visually significant refractive errors according to the <italic toggle="yes">Pediatric Eye Evaluations Preferred Practice Pattern published</italic> by AAO and <italic toggle="yes">Vision Screening Committee Guidelines</italic> published by AAPOS (<xref rid="pone.0324366.s001" ref-type="supplementary-material">S1 Table</xref>), including visually significant myopia (29, 19.6%), visually significant hyperopia (47, 31.8%), visually significant astigmatism (104, 70.3%), and visually significant anisometropia (12, 8.1%) (<xref rid="pone.0324366.g001" ref-type="fig">Fig 1a</xref>). A total of 62 children (41.9%) exhibited strabismus, with 51 having esotropia, seven having exotropia, three having inferior oblique muscle overaction, and one having dissociated vertical deviation (<xref rid="pone.0324366.g001" ref-type="fig">Fig 1b</xref>). Nystagmus was observed in 41 children (27.7%), nasolacrimal duct obstruction in 12 children (8.1%), and glaucoma in four children (2.7%). Cataracts were found in 15 children (10.1%), with a predominance in adolescents. No children were given a diagnosis of keratoconus. Only cataracts show a statistically significant difference across age subgroups, while all other conditions demonstrate no statistically significant differences in prevalence across the age subgroups. The detailed data are presented in <xref rid="pone.0324366.t001" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="pone.0324366.t001"><object-id pub-id-type="doi">10.1371/journal.pone.0324366.t001</object-id><label>Table 1</label><caption><title>Ophthalmic abnormality prevalence in children with Down syndrome.</title></caption><alternatives><graphic xlink:href="pone.0324366.t001" id="pone.0324366.t001g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Age groups</th><th align="left" rowspan="1" colspan="1">Early childhood</th><th align="left" rowspan="1" colspan="1">Middle childhood</th><th align="left" rowspan="1" colspan="1">Adolescence</th><th align="left" rowspan="1" colspan="1">P value</th><th align="left" rowspan="1" colspan="1">Total</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number of children</td><td align="left" rowspan="1" colspan="1">101</td><td align="left" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">148</td></tr><tr><td align="left" rowspan="1" colspan="1">Mean age of first visit (months)</td><td align="left" rowspan="1" colspan="1">32.8</td><td align="left" rowspan="1" colspan="1">99.8</td><td align="left" rowspan="1" colspan="1">179.5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">64.9&#x02009;&#x000b1;&#x02009;56.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Visually significant<break/>refractive error</td><td align="left" rowspan="1" colspan="1">71 (70.3%)</td><td align="left" rowspan="1" colspan="1">22 (81.5%)</td><td align="left" rowspan="1" colspan="1">19 (95.0%)</td><td align="left" rowspan="1" colspan="1">0.526</td><td align="left" rowspan="1" colspan="1">112 (75.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Myopia</td><td align="left" rowspan="1" colspan="1">18 (17.8%)</td><td align="left" rowspan="1" colspan="1">5 (18.5%)</td><td align="left" rowspan="1" colspan="1">6 (30.0%)</td><td align="left" rowspan="1" colspan="1">0.475</td><td align="left" rowspan="1" colspan="1">29 (19.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hyperopia</td><td align="left" rowspan="1" colspan="1">30 (29.7%)</td><td align="left" rowspan="1" colspan="1">10 (37.3%)</td><td align="left" rowspan="1" colspan="1">7 (35.0%)</td><td align="left" rowspan="1" colspan="1">0.206</td><td align="left" rowspan="1" colspan="1">47 (31.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Astigmatism</td><td align="left" rowspan="1" colspan="1">65 (64.4%)</td><td align="left" rowspan="1" colspan="1">21 (77.8%)</td><td align="left" rowspan="1" colspan="1">18 (90.0%)</td><td align="left" rowspan="1" colspan="1">0.598</td><td align="left" rowspan="1" colspan="1">104 (70.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Anisometropia</td><td align="left" rowspan="1" colspan="1">6 (5.9%)</td><td align="left" rowspan="1" colspan="1">4 (14.8%)</td><td align="left" rowspan="1" colspan="1">2 (10.0%)</td><td align="left" rowspan="1" colspan="1">0.666</td><td align="left" rowspan="1" colspan="1">12 (8.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Strabismus</td><td align="left" rowspan="1" colspan="1">44 (43.6%)</td><td align="left" rowspan="1" colspan="1">8 (29.6%)</td><td align="left" rowspan="1" colspan="1">10 (50.0%)</td><td align="left" rowspan="1" colspan="1">0.493</td><td align="left" rowspan="1" colspan="1">62 (41.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Esotropia</td><td align="left" rowspan="1" colspan="1">38 (37.6%)</td><td align="left" rowspan="1" colspan="1">5 (18.5%)</td><td align="left" rowspan="1" colspan="1">8 (40.0%)</td><td align="left" rowspan="1" colspan="1">0.708</td><td align="left" rowspan="1" colspan="1">51 (34.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Exotropia</td><td align="left" rowspan="1" colspan="1">4 (4.0%)</td><td align="left" rowspan="1" colspan="1">2 (7.4%)</td><td align="left" rowspan="1" colspan="1">1 (5.0%)</td><td align="left" rowspan="1" colspan="1">0.229</td><td align="left" rowspan="1" colspan="1">7 (4.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Others</td><td align="left" rowspan="1" colspan="1">2 (2.0%)</td><td align="left" rowspan="1" colspan="1">1 (3.7%)</td><td align="left" rowspan="1" colspan="1">1 (5.0%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4 (2.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Nystagmus</td><td align="left" rowspan="1" colspan="1">29 (28.7%)</td><td align="left" rowspan="1" colspan="1">7 (25.9%)</td><td align="left" rowspan="1" colspan="1">5 (25.0%)</td><td align="left" rowspan="1" colspan="1">0.059</td><td align="left" rowspan="1" colspan="1">41 (27.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Cataract</td><td align="left" rowspan="1" colspan="1">4 (4.0%)</td><td align="left" rowspan="1" colspan="1">4 (14.8%)</td><td align="left" rowspan="1" colspan="1">7 (35.0%)</td><td align="left" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="left" rowspan="1" colspan="1">15 (10.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Nasolacrimal duct obstruction</td><td align="left" rowspan="1" colspan="1">10 (9.9%)</td><td align="left" rowspan="1" colspan="1">2 (7.4%)</td><td align="left" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" rowspan="1" colspan="1">0.639</td><td align="left" rowspan="1" colspan="1">12 (8.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Glaucoma</td><td align="left" rowspan="1" colspan="1">3 (2.97%)</td><td align="left" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" rowspan="1" colspan="1">1 (5.0%)</td><td align="left" rowspan="1" colspan="1">0.437</td><td align="left" rowspan="1" colspan="1">4 (2.7%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Keratoconus</td><td align="left" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" rowspan="1" colspan="1">0 (0.0%)</td><td align="left" rowspan="1" colspan="1">1.000</td><td align="left" rowspan="1" colspan="1">0 (0.0%)</td></tr></tbody></table></alternatives></table-wrap><fig position="float" id="pone.0324366.g001"><object-id pub-id-type="doi">10.1371/journal.pone.0324366.g001</object-id><label>Fig 1</label><caption><title>Prevalence of refractive errors, visually significant refractive errors (a), and strabismus types (b) in children with Down syndrome (DS).</title></caption><graphic xlink:href="pone.0324366.g001" position="float"/></fig></sec><sec id="sec012"><title>3.2. Annual refractive changes in DS children</title><p>In the examinations of the 148 children, 134 eyes from 67 children (35 boys and 32 girls) had complete records of refractive status with a follow-up period of more than one year, with an average follow-up period of 4.06&#x02009;&#x000b1;&#x02009;2.47 years. The follow-up periods were 3.77&#x02009;&#x000b1;&#x02009;2.18 years, 4.19&#x02009;&#x000b1;&#x02009;2.66 years, and 4.79&#x02009;&#x000b1;&#x02009;2.95 years for the age subgroups of early childhood, middle childhood and adolescence, respectively. Statistical analysis revealed no significant differences between the left and right eyes. The groups of children in early childhood, middle childhood and adolescence with complete records comprised 38, 17, and 12 children, respectively. For refractive change analysis, we excluded eyes with cataracts due to potential confounding. Of the remaining 116 eyes, 41 myopic eyes (spherical equivalence&#x02009;&#x02264; &#x02212;0.5 D) and 56 hyperopic eyes (spherical equivalence&#x02009;&#x02265;&#x02009;0.5 D) were included in subgroup analysis. In all children with complete refraction data, the annual refractive changes were &#x02212;0.16&#x02009;&#x000b1;&#x02009;0.65 D, 0.02&#x02009;&#x000b1;&#x02009;0.67 D, and &#x02212;0.29&#x02009;&#x000b1;&#x02009;0.62 D in the total, myopic, and hyperopic eye subgroups, respectively. In the hyperopic subgroup, the adolescents exhibited a significantly higher annual refractive change compared with the subgroups of children in early childhood (<italic toggle="yes">P</italic>&#x02009;=&#x02009;0.0371) and middle childhood (<italic toggle="yes">P</italic>&#x02009;=&#x02009;0.0292) by Bonferroni post hoc test. The detailed data are presented in <xref rid="pone.0324366.t002" ref-type="table">Table 2</xref>.</p><table-wrap position="float" id="pone.0324366.t002"><object-id pub-id-type="doi">10.1371/journal.pone.0324366.t002</object-id><label>Table 2</label><caption><title>Annual refractive changes in children with Down syndrome in various age subgroups.</title></caption><alternatives><graphic xlink:href="pone.0324366.t002" id="pone.0324366.t002g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Groups</th><th align="left" rowspan="1" colspan="1">Subgroups</th><th align="left" rowspan="1" colspan="1">Annual refractive changes<break/>&#x000b1; standard deviation</th><th align="left" rowspan="1" colspan="1">ANOVA (<italic toggle="yes">P</italic> value)</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1">All</td><td align="left" rowspan="1" colspan="1">Early childhood</td><td align="left" rowspan="1" colspan="1">-0.13&#x02009;&#x000b1;&#x02009;0.69D</td><td align="left" rowspan="4" colspan="1">0.3722</td></tr><tr><td align="left" rowspan="1" colspan="1">Middle childhood</td><td align="left" rowspan="1" colspan="1">-0.12&#x02009;&#x000b1;&#x02009;0.38D</td></tr><tr><td align="left" rowspan="1" colspan="1">Adolescence</td><td align="left" rowspan="1" colspan="1">-0.34&#x02009;&#x000b1;&#x02009;0.83D</td></tr><tr><td align="left" rowspan="1" colspan="1">Overall</td><td align="left" rowspan="1" colspan="1">-0.16&#x02009;&#x000b1;&#x02009;0.65D</td></tr><tr><td align="left" rowspan="4" colspan="1">Myopia</td><td align="left" rowspan="1" colspan="1">Early childhood</td><td align="left" rowspan="1" colspan="1">0.03&#x02009;&#x000b1;&#x02009;0.83D</td><td align="left" rowspan="4" colspan="1">0.9617</td></tr><tr><td align="left" rowspan="1" colspan="1">Middle childhood</td><td align="left" rowspan="1" colspan="1">-0.03&#x02009;&#x000b1;&#x02009;0.47D</td></tr><tr><td align="left" rowspan="1" colspan="1">Adolescence</td><td align="left" rowspan="1" colspan="1">0.02&#x02009;&#x000b1;&#x02009;0.46D</td></tr><tr><td align="left" rowspan="1" colspan="1">Overall</td><td align="left" rowspan="1" colspan="1">0.02&#x02009;&#x000b1;&#x02009;0.67D</td></tr><tr><td align="left" rowspan="4" colspan="1">Hyperopia</td><td align="left" rowspan="1" colspan="1">Early childhood</td><td align="left" rowspan="1" colspan="1">-0.25&#x02009;&#x000b1;&#x02009;0.54D</td><td align="left" rowspan="4" colspan="1">
<bold>0.0264</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Middle childhood</td><td align="left" rowspan="1" colspan="1">-0.15&#x02009;&#x000b1;&#x02009;0.32D</td></tr><tr><td align="left" rowspan="1" colspan="1">Adolescence</td><td align="left" rowspan="1" colspan="1">-0.91&#x02009;&#x000b1;&#x02009;1.22D</td></tr><tr><td align="left" rowspan="1" colspan="1">Overall</td><td align="left" rowspan="1" colspan="1">-0.29&#x02009;&#x000b1;&#x02009;0.62D</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec013"><title>3.3. Associated factors of refractive changes in DS children</title><p>Linear regression analysis revealed that age and baseline spherical equivalence substantially influenced refractive changes, and indicated that older DS children and DS children with higher spherical equivalence exhibited a greater tendency for myopic shift. In the myopic eyes subgroup, visually significant astigmatism was identified as the only significant factor influencing myopic progression. In the hyperopic eyes subgroup, factors including male sex, age, esotropia, and higher baseline spherical equivalence were identified as contributing to myopic shift. The detailed data are presented in <xref rid="pone.0324366.t003" ref-type="table">Table 3</xref>.</p><table-wrap position="float" id="pone.0324366.t003"><object-id pub-id-type="doi">10.1371/journal.pone.0324366.t003</object-id><label>Table 3</label><caption><title>Factors associated with refractive changes in children with Down syndrome.</title></caption><alternatives><graphic xlink:href="pone.0324366.t003" id="pone.0324366.t003g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" colspan="2" rowspan="1">All</th><th align="left" colspan="2" rowspan="1">Myopia</th><th align="left" colspan="2" rowspan="1">Hyperopia</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Coefficient (Standard error)</td><td align="left" rowspan="1" colspan="1">P value</td><td align="left" rowspan="1" colspan="1">Coefficient (Standard error)</td><td align="left" rowspan="1" colspan="1">P value</td><td align="left" rowspan="1" colspan="1">Coefficient (Standard error)</td><td align="left" rowspan="1" colspan="1">P value</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex<break/>&#x02003;Male&#x02009;=&#x02009;1</td><td align="left" rowspan="1" colspan="1">-0.071 (0.121)</td><td align="left" rowspan="1" colspan="1">0.562</td><td align="left" rowspan="1" colspan="1">0.360 (0.194)</td><td align="left" rowspan="1" colspan="1">0.072</td><td align="left" rowspan="1" colspan="1">-0.382 (0.15)</td><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.014</italic>
</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="left" rowspan="1" colspan="1">-0.053 (0.014)</td><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">&#x0003c;0.001</italic>
</bold>
</td><td align="left" rowspan="1" colspan="1">-0.019 (0.024)</td><td align="left" rowspan="1" colspan="1">0.420</td><td align="left" rowspan="1" colspan="1">-0.037 (0.017)</td><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.038</italic>
</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Strabismus</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Esotropia</td><td align="left" rowspan="1" colspan="1">-0.107 (0.127)</td><td align="left" rowspan="1" colspan="1">0.399</td><td align="left" rowspan="1" colspan="1">0.405 (0.203)</td><td align="left" rowspan="1" colspan="1">0.054</td><td align="left" rowspan="1" colspan="1">-0.546 (0.154)</td><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.001</italic>
</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline spherical equivalence</td><td align="left" rowspan="1" colspan="1">-0.042 (0.014)</td><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.005</italic>
</bold>
</td><td align="left" rowspan="1" colspan="1">-0.016 (0.022)</td><td align="left" rowspan="1" colspan="1">0.486</td><td align="left" rowspan="1" colspan="1">-0.101 (0.044)</td><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.026</italic>
</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Visually significant astigmatism</td><td align="left" rowspan="1" colspan="1">-0.213 (0.215)</td><td align="left" rowspan="1" colspan="1">0.324</td><td align="left" rowspan="1" colspan="1">-1.245 (0.329)</td><td align="left" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.001</italic>
</bold>
</td><td align="left" rowspan="1" colspan="1">0.122 (0.279)</td><td align="left" rowspan="1" colspan="1">0.665</td></tr></tbody></table></alternatives></table-wrap></sec></sec><sec sec-type="conclusions" id="sec014"><title>4. Discussion</title><p>This study examines the prevalence of ophthalmological disorders in Taiwanese children with DS at the special clinic of a tertiary medical center. The research makes a unique contribution to the field by providing unprecedented data on the prevalence of ocular abnormalities and annual refractive changes in Taiwanese DS children, while also investigating the demographic and clinical factors associated with these refractive changes across different refractive status subgroups. Our study has substantial clinical and public health implications for ophthalmologic care in children with DS, given that many of these ocular manifestations are amenable to intervention. Implementation of early screening protocols may be crucial for preventing vision loss in this vulnerable population.</p><p>In <xref rid="pone.0324366.t001" ref-type="table">Table 1</xref>, cataract prevalence was the only ophthalmic condition demonstrating significant age-related variation in our DS cohort. Although congenital and cerulean cataracts are more common in DS populations and are now more easily detected through newborn red reflex screening, our age-related findings present an intriguing contrast to existing literature. While one study [<xref rid="pone.0324366.ref018" ref-type="bibr">18</xref>] of older DS children over 30 years old found cataracts in 72.2% of eyes (26.1% congenital, 44.9% age-related), yet another study [<xref rid="pone.0324366.ref019" ref-type="bibr">19</xref>] found no evidence supporting early-onset age-related cataracts. Further longitudinal studies are required to better understand the progression of cataract development in children with DS.</p><p>To compare with the ophthalmic abnormalities research regarding DS children, we did a comprehensive literature research on this topic. In <xref rid="pone.0324366.t004" ref-type="table">Table 4</xref> [<xref rid="pone.0324366.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0324366.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0324366.ref009" ref-type="bibr">9</xref>&#x02013;<xref rid="pone.0324366.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0324366.ref020" ref-type="bibr">20</xref>&#x02013;<xref rid="pone.0324366.ref033" ref-type="bibr">33</xref>], a comprehensive comparison of ophthalmic abnormality prevalence in DS children across different geographical regions, including our current study in Taiwan. Our study included 148 children with DS, 82 males and 66 females aged 0&#x02013;18 years, representing one of the larger cohorts among the comparative studies. We systematically categorized studies according to geographic region and ethnicity as Asia, Europe, Americas, and Africa. For each study, we documented the following parameters: country or region, age range of participants, sample size, and prevalence expressed as percentages of various ophthalmic abnormalities in DS children. The documented ophthalmic findings included overall abnormality rates, myopia, hyperopia, astigmatism, and visually significant refractive errors based on age-stratified criteria. Additional ocular conditions recorded comprised strabismus subtypes including esotropia and exotropia, nystagmus, nasolacrimal duct obstruction, lens opacities or cataracts, glaucoma, and keratoconus. Ocular abnormalities were found in 58.0% to 97.2% of children with DS, with higher prevalence rates among Asian and European populations compared to American and African cohorts; though this variation may reflect differences in classified methodologies rather than true ethnic distinctions.</p><table-wrap position="float" id="pone.0324366.t004"><object-id pub-id-type="doi">10.1371/journal.pone.0324366.t004</object-id><label>Table 4</label><caption><title>Comparison of ophthalmic abnormality prevalence in children with Down syndrome.</title></caption><alternatives><graphic xlink:href="pone.0324366.t004" id="pone.0324366.t004g" position="float"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Country/<break/>Region</th><th align="left" rowspan="1" colspan="1">Age</th><th align="left" rowspan="1" colspan="1">Sample size</th><th align="left" rowspan="1" colspan="1">Overall</th><th align="left" rowspan="1" colspan="1">Myopia</th><th align="left" rowspan="1" colspan="1">Hyperopia</th><th align="left" rowspan="1" colspan="1">Astigmatism</th><th align="left" rowspan="1" colspan="1">Visually significant refractive error</th><th align="left" rowspan="1" colspan="1">Strabismus</th><th align="left" rowspan="1" colspan="1">ET&#x02020;</th><th align="left" rowspan="1" colspan="1">XT&#x02021;</th><th align="left" rowspan="1" colspan="1">Nystagmus</th><th align="left" rowspan="1" colspan="1">NLDO&#x000a7;</th><th align="left" rowspan="1" colspan="1">Cataract/ lens opacity</th><th align="left" rowspan="1" colspan="1">Glaucoma</th><th align="left" rowspan="1" colspan="1">Keratoconus</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<bold>Asia</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Current study, 2025</td><td align="left" rowspan="1" colspan="1">
<bold>Taiwan</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0y-18y</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>148 (M:82, F:66)</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>89.2%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>20.9%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>55.4%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>70.3%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>75.7%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>41.9%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>34.5%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>4.7%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>27.7%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>8.1%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>10.1%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>2.7%</bold>
</td><td align="left" rowspan="1" colspan="1">
<bold>0.0%</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Wong and Ho, 1997</td><td align="left" rowspan="1" colspan="1">Hong Kong</td><td align="left" rowspan="1" colspan="1">3m-13y</td><td align="left" rowspan="1" colspan="1">140 (M:82, F:58)</td><td align="left" rowspan="1" colspan="1">69.0%</td><td align="left" rowspan="1" colspan="1">12.0%</td><td align="left" rowspan="1" colspan="1">42.0%</td><td align="left" rowspan="1" colspan="1">8.0%</td><td align="left" rowspan="1" colspan="1">58.0%</td><td align="left" rowspan="1" colspan="1">22.0%</td><td align="left" rowspan="1" colspan="1">20.0%</td><td align="left" rowspan="1" colspan="1">1.8%</td><td align="left" rowspan="1" colspan="1">11.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.0%</td><td align="left" rowspan="1" colspan="1">0.7%</td><td align="left" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="left" rowspan="1" colspan="1">Merrick and Koslowe, 2001</td><td align="left" rowspan="1" colspan="1">Israel</td><td align="left" rowspan="1" colspan="1">5y-18y</td><td align="left" rowspan="1" colspan="1">86 (M:43, F;43)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">91.0%</td><td align="left" rowspan="1" colspan="1">33.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">9.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">37.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">13.0%</td></tr><tr><td align="left" rowspan="1" colspan="1">Kim et al., 2002</td><td align="left" rowspan="1" colspan="1">South Korea</td><td align="left" rowspan="1" colspan="1">6m-14y</td><td align="left" rowspan="1" colspan="1">123 (M:81, F:42)</td><td align="left" rowspan="1" colspan="1">91.0%</td><td align="left" rowspan="1" colspan="1">25.0%</td><td align="left" rowspan="1" colspan="1">28.0%</td><td align="left" rowspan="1" colspan="1">31.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">25.0%</td><td align="left" rowspan="1" colspan="1">14.5%</td><td align="left" rowspan="1" colspan="1">10.5%</td><td align="left" rowspan="1" colspan="1">22.0%</td><td align="left" rowspan="1" colspan="1">17.0%</td><td align="left" rowspan="1" colspan="1">3.0%</td><td align="left" rowspan="1" colspan="1">0.8%</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Liza-Sharmini et al., 2006</td><td align="left" rowspan="1" colspan="1">Malaysia</td><td align="left" rowspan="1" colspan="1">1m-17y</td><td align="left" rowspan="1" colspan="1">60 (M:26, F:34)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">29.2%</td><td align="left" rowspan="1" colspan="1">25.0%</td><td align="left" rowspan="1" colspan="1">8.3%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">26.7%</td><td align="left" rowspan="1" colspan="1">26.7%</td><td align="left" rowspan="1" colspan="1">0.0%</td><td align="left" rowspan="1" colspan="1">33.3%</td><td align="left" rowspan="1" colspan="1">3.3%</td><td align="left" rowspan="1" colspan="1">13.3%</td><td align="left" rowspan="1" colspan="1">6.7%</td><td align="left" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="left" rowspan="1" colspan="1">Kim et al., 2009</td><td align="left" rowspan="1" colspan="1">South Korea</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">172 (M:85, F:87)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">40.1%</td><td align="left" rowspan="1" colspan="1">46.5%</td><td align="left" rowspan="1" colspan="1">66.8%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">34.3%</td><td align="left" rowspan="1" colspan="1">22.1%</td><td align="left" rowspan="1" colspan="1">10.5%</td><td align="left" rowspan="1" colspan="1">29.1%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Paudel et al., 2010</td><td align="left" rowspan="1" colspan="1">Nepal</td><td align="left" rowspan="1" colspan="1">4m-18y</td><td align="left" rowspan="1" colspan="1">36 (M:19, F:17)</td><td align="left" rowspan="1" colspan="1">97.2%</td><td align="left" rowspan="1" colspan="1">25.0%</td><td align="left" rowspan="1" colspan="1">55.0%</td><td align="left" rowspan="1" colspan="1">44.0%</td><td align="left" rowspan="1" colspan="1">80.0%</td><td align="left" rowspan="1" colspan="1">5.6%</td><td align="left" rowspan="1" colspan="1">0.0%</td><td align="left" rowspan="1" colspan="1">0.0%</td><td align="left" rowspan="1" colspan="1">28.0%</td><td align="left" rowspan="1" colspan="1">22.0%</td><td align="left" rowspan="1" colspan="1">5.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Han et al., 2012</td><td align="left" rowspan="1" colspan="1">South Korea</td><td align="left" rowspan="1" colspan="1">2y-36y</td><td align="left" rowspan="1" colspan="1">41</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">48.8%</td><td align="left" rowspan="1" colspan="1">36.6%</td><td align="left" rowspan="1" colspan="1">51.2%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">43.9%</td><td align="left" rowspan="1" colspan="1">23.4%</td><td align="left" rowspan="1" colspan="1">19.5%</td><td align="left" rowspan="1" colspan="1">31.7%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Makateb et al., 2020</td><td align="left" rowspan="1" colspan="1">Iran</td><td align="left" rowspan="1" colspan="1">10y-30y</td><td align="left" rowspan="1" colspan="1">226 (M;118, F:108)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">33.6%</td><td align="left" rowspan="1" colspan="1">45.6%</td><td align="left" rowspan="1" colspan="1">20.3%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">23.4%</td><td align="left" rowspan="1" colspan="1">21.2%</td><td align="left" rowspan="1" colspan="1">0.9%</td><td align="left" rowspan="1" colspan="1">11.7%</td><td align="left" rowspan="1" colspan="1">2.9%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<bold>Europe</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Berk et al., 1996</td><td align="left" rowspan="1" colspan="1">Turkey</td><td align="left" rowspan="1" colspan="1">2m-25y</td><td align="left" rowspan="1" colspan="1">55 (M:38, F:17)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">12.6%</td><td align="left" rowspan="1" colspan="1">52.7%</td><td align="left" rowspan="1" colspan="1">43.6%</td><td align="left" rowspan="1" colspan="1">87.3%</td><td align="left" rowspan="1" colspan="1">21.8%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">12.7%</td><td align="left" rowspan="1" colspan="1">21.8%</td><td align="left" rowspan="1" colspan="1">20.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Fimiani et al., 2007</td><td align="left" rowspan="1" colspan="1">Italy</td><td align="left" rowspan="1" colspan="1">1m-18y</td><td align="left" rowspan="1" colspan="1">157 (M:70, F:87)</td><td align="left" rowspan="1" colspan="1">100.0%</td><td align="left" rowspan="1" colspan="1">9.0%</td><td align="left" rowspan="1" colspan="1">59.0%</td><td align="left" rowspan="1" colspan="1">28.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">36.0%</td><td align="left" rowspan="1" colspan="1">28.9%</td><td align="left" rowspan="1" colspan="1">7.1%</td><td align="left" rowspan="1" colspan="1">6.0%</td><td align="left" rowspan="1" colspan="1">22.0%</td><td align="left" rowspan="1" colspan="1">11.0%</td><td align="left" rowspan="1" colspan="1">0.0%</td><td align="left" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="left" rowspan="1" colspan="1">Creavin et al., 2010</td><td align="left" rowspan="1" colspan="1">UK</td><td align="left" rowspan="1" colspan="1">0-16y</td><td align="left" rowspan="1" colspan="1">98</td><td align="left" rowspan="1" colspan="1">96.0%</td><td align="left" rowspan="1" colspan="1">17.0%</td><td align="left" rowspan="1" colspan="1">83.0%</td><td align="left" rowspan="1" colspan="1">74.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">65.0%</td><td align="left" rowspan="1" colspan="1">50.1%</td><td align="left" rowspan="1" colspan="1">15.0%</td><td align="left" rowspan="1" colspan="1">9.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">4.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ljubic et al. 2011</td><td align="left" rowspan="1" colspan="1">Macedonia and Croatia</td><td align="left" rowspan="1" colspan="1">1y-34y</td><td align="left" rowspan="1" colspan="1">170 (M:98, F:72)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">20.7%</td><td align="left" rowspan="1" colspan="1">55.2%</td><td align="left" rowspan="1" colspan="1">72.4%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">26.5%</td><td align="left" rowspan="1" colspan="1">18.8%</td><td align="left" rowspan="1" colspan="1">5.3%</td><td align="left" rowspan="1" colspan="1">11%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ljubic et al., 2015</td><td align="left" rowspan="1" colspan="1">Croatia</td><td align="left" rowspan="1" colspan="1">mean 10.6 y</td><td align="left" rowspan="1" colspan="1">51 (M:22, F:29)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">20.4%</td><td align="left" rowspan="1" colspan="1">53.1%</td><td align="left" rowspan="1" colspan="1">68.8%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">29.4%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">2.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">8.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Purpura et al., 2019</td><td align="left" rowspan="1" colspan="1">Italy</td><td align="left" rowspan="1" colspan="1">2m-18m</td><td align="left" rowspan="1" colspan="1">42 (M;20, F:22)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">11.9%</td><td align="left" rowspan="1" colspan="1">83.3%</td><td align="left" rowspan="1" colspan="1">45.2%</td><td align="left" rowspan="1" colspan="1">100.0%</td><td align="left" rowspan="1" colspan="1">21.4%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">16.7%</td><td align="left" rowspan="1" colspan="1">7.1%</td><td align="left" rowspan="1" colspan="1">7.1%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Ugurlu et al., 2020</td><td align="left" rowspan="1" colspan="1">Turkey</td><td align="left" rowspan="1" colspan="1">7y-18y</td><td align="left" rowspan="1" colspan="1">44 (M: 21, F:23)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">29.5%</td><td align="left" rowspan="1" colspan="1">70.5%</td><td align="left" rowspan="1" colspan="1">70.5%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">22.7%</td><td align="left" rowspan="1" colspan="1">18.2%</td><td align="left" rowspan="1" colspan="1">4.5%</td><td align="left" rowspan="1" colspan="1">2.3%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">31.8%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<bold>Americas</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Caputo et al., 1989</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">3.5m-26y</td><td align="left" rowspan="1" colspan="1">187 (M;102, F:85)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">22.5%</td><td align="left" rowspan="1" colspan="1">21.0%</td><td align="left" rowspan="1" colspan="1">22.5%</td><td align="left" rowspan="1" colspan="1">30.0%</td><td align="left" rowspan="1" colspan="1">57.0%</td><td align="left" rowspan="1" colspan="1">51.0%</td><td align="left" rowspan="1" colspan="1">2.0%</td><td align="left" rowspan="1" colspan="1">29.0%</td><td align="left" rowspan="1" colspan="1">5.0%</td><td align="left" rowspan="1" colspan="1">11.2%</td><td align="left" rowspan="1" colspan="1">5.3%</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Roizen et al., 1994</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1">77</td><td align="left" rowspan="1" colspan="1">60.0%</td><td align="left" rowspan="1" colspan="1">14.3%</td><td align="left" rowspan="1" colspan="1">6.5%</td><td align="left" rowspan="1" colspan="1">6.5%</td><td align="left" rowspan="1" colspan="1">35.0%</td><td align="left" rowspan="1" colspan="1">27.0%</td><td align="left" rowspan="1" colspan="1">16.9%</td><td align="left" rowspan="1" colspan="1">1.4%</td><td align="left" rowspan="1" colspan="1">20.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">5.0%</td><td align="left" rowspan="1" colspan="1">1.4%</td><td align="left" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="left" rowspan="1" colspan="1">Umfress et al., 2019</td><td align="left" rowspan="1" colspan="1">USA</td><td align="left" rowspan="1" colspan="1">&#x0003c;18 y</td><td align="left" rowspan="1" colspan="1">689</td><td align="left" rowspan="1" colspan="1">61.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">12.5%</td><td align="left" rowspan="1" colspan="1">38.0%</td><td align="left" rowspan="1" colspan="1">36.0%</td><td align="left" rowspan="1" colspan="1">29.6%</td><td align="left" rowspan="1" colspan="1">4.0%</td><td align="left" rowspan="1" colspan="1">17.0%</td><td align="left" rowspan="1" colspan="1">8.0%</td><td align="left" rowspan="1" colspan="1">6.2%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">
<bold>Africa</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Adio et al., 2012</td><td align="left" rowspan="1" colspan="1">Nigeria</td><td align="left" rowspan="1" colspan="1">6m-28y</td><td align="left" rowspan="1" colspan="1">42 (M:22, F:20)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">38.1%</td><td align="left" rowspan="1" colspan="1">9.5%</td><td align="left" rowspan="1" colspan="1">28.6%</td><td align="left" rowspan="1" colspan="1">76.2%</td><td align="left" rowspan="1" colspan="1">9.5%</td><td align="left" rowspan="1" colspan="1">7.1%</td><td align="left" rowspan="1" colspan="1">2.4%</td><td align="left" rowspan="1" colspan="1">4.8%</td><td align="left" rowspan="1" colspan="1">2.4%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Afifi et al., 2013</td><td align="left" rowspan="1" colspan="1">Egypt</td><td align="left" rowspan="1" colspan="1">2m-10y</td><td align="left" rowspan="1" colspan="1">90 (M:47, F:43)</td><td align="left" rowspan="1" colspan="1">58.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">41.0%</td><td align="left" rowspan="1" colspan="1">14.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.0%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">6.0%</td><td align="left" rowspan="1" colspan="1">0.0%</td><td align="left" rowspan="1" colspan="1">0.0%</td></tr><tr><td align="left" rowspan="1" colspan="1">Aghaji et al., 2013</td><td align="left" rowspan="1" colspan="1">Nigeria</td><td align="left" rowspan="1" colspan="1">5-15y</td><td align="left" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">76.40%</td><td align="left" rowspan="1" colspan="1">33.3%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">13.3%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">3.30%</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>&#x02020; ET: esotropia; &#x02021;XT: exotropia; &#x000a7;NLDO: nasolacrimal duct obstruction; N/A: not available.</p></fn></table-wrap-foot></table-wrap><p>Refractive errors were the predominant finding in our cohort, consistent with published literature. Geographic variations were notable, with American studies [<xref rid="pone.0324366.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0324366.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0324366.ref022" ref-type="bibr">22</xref>] reporting lower prevalence rates (&#x0003c;40%). Our cohort showed myopia in 20.9%, hyperopia in 55.4%, and markedly higher astigmatism at 70.3%, aligning with Akinci et al&#x02019;s [<xref rid="pone.0324366.ref034" ref-type="bibr">34</xref>] observation of lower myopia but higher hyperopia and astigmatism in DS children. The high prevalence of astigmatism in DS children can be attributed to the characteristic craniofacial features. The mechanical effect of upward slanting palpebral fissures common in Asian individuals [<xref rid="pone.0324366.ref035" ref-type="bibr">35</xref>] may explain the high astigmatism prevalence in our cohort. Furthermore, evidence suggests that the prevalence of substantial astigmatism in DS children tends to increase with age.</p><p>Analysis of refractive evolution in our cohort revealed that children with DS demonstrated an annual refractive shift of -0.16&#x02009;&#x000b1;&#x02009;0.65 D in this Taiwanese population. Given the paucity of longitudinal refractive data in DS populations, we contextualized our findings through comparison with typically developing children. In non-DS urban children, documented annual myopic progression rates were -0.55 D in European and -0.82 D in Asian populations, with progression rates inversely correlating with baseline age [<xref rid="pone.0324366.ref036" ref-type="bibr">36</xref>]. While prolonged near-work activities have been strongly associated with myopia development in typically developing children [<xref rid="pone.0324366.ref037" ref-type="bibr">37</xref>], such sustained near-vision tasks are less frequently observed in children with DS, potentially contributing to their distinct refractive progression pattern.</p><p>Linear regression analysis identified age and baseline spherical equivalence as the critical determinants of myopic shifts in DS children. While typically developing children show prominent myopic shifts at younger ages due to axial length elongation [<xref rid="pone.0324366.ref038" ref-type="bibr">38</xref>], DS children demonstrate an altered pattern. Previous studies suggest impaired emmetropization in DS [<xref rid="pone.0324366.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0324366.ref009" ref-type="bibr">9</xref>,<xref rid="pone.0324366.ref035" ref-type="bibr">35</xref>,<xref rid="pone.0324366.ref039" ref-type="bibr">39</xref>], where initial refractive errors tend to persist with age. However, older hyperopic DS children still exhibited pronounced myopic shifts with age [<xref rid="pone.0324366.ref039" ref-type="bibr">39</xref>], potentially due to the increased near-vision demands.</p><p>In myopic eyes, visually significant astigmatism emerged as the sole factor influencing myopic progression, consistent with findings in Chinese preschool children where greater astigmatism correlated with increased axial length elongation and myopic shift [<xref rid="pone.0324366.ref040" ref-type="bibr">40</xref>]. In hyperopic DS children, myopic shifts strongly correlated with male sex, age, esotropia, and baseline spherical equivalence. While meta-analysis data showed hyperopia inversely correlates with age in typically developing children [<xref rid="pone.0324366.ref041" ref-type="bibr">41</xref>], the relationship between hyperopia and strabismus in DS remains complex. Ljubic et al [<xref rid="pone.0324366.ref024" ref-type="bibr">24</xref>] reported lower strabismus rates in high-grade versus low-grade hyperopia, and Cho et al [<xref rid="pone.0324366.ref042" ref-type="bibr">42</xref>] found accommodative esotropia typically develops between ages two and three. However, still some studies found no significant association between strabismus and refractive errors in DS children [<xref rid="pone.0324366.ref039" ref-type="bibr">39</xref>].</p><p>Several limitations warrant consideration in our study. First, the challenges in accessing healthcare services for subjects with DS may result in selection bias, as parents of DS children with mild symptoms might be less likely to seek medical attention, potentially affecting the reported prevalence rates. Second, the inherent difficulties these children face during eye examinations challenged the acquisition of accurate refractive data. Third, high loss to follow-up rates resulted in a limited sample size.</p><p>In this comprehensive analysis of ophthalmic disorders in Taiwanese children with DS aged under 18 years, combined with an extensive literature review, we observed a high prevalence of visually significant refractive errors (75.7%), with astigmatism (70.3%) notably exceeding rates reported in previous studies of Asian children with DS. Our longitudinal analysis revealed a modest annual refractive change of &#x02212;0.16&#x02009;&#x000b1;&#x02009;0.65 diopters, with age and baseline spherical equivalence emerging as significant contributing factors, which was the first annual refractive changes statistics of Asian children with DS.</p><p>Future longitudinal studies with larger cohorts are needed to validate our findings on ophthalmic disorders in Asian children with DS. Our unprecedented data on annual refractive progression and the influence of demographic and ophthalmological factors contribute to the growing understanding of DS-related eye disorders in Asian populations. These insights may guide the development of targeted screening protocols and intervention strategies to address the unique ophthalmic needs of children with DS. Standardized classification methods and comprehensive follow-up protocols would further enhance our understanding of refractive evolution in this population.</p></sec><sec id="sec015" sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="pone.0324366.s001" position="float" content-type="local-data"><label>S1 Table</label><caption><title>Definitions of visually significant refractive error.</title><p>(DOCX)</p></caption><media xlink:href="pone.0324366.s001.docx"/></supplementary-material><supplementary-material id="pone.0324366.s002" position="float" content-type="local-data"><label>S1 Dataset</label><caption><title>DS raw data.</title><p>(XLSX)</p></caption><media xlink:href="pone.0324366.s002.xlsx"/></supplementary-material></sec></body><back><ack><p>We would like to acknowledge the ophthalmologists and optometrists working in the National Taiwan University Hospital for the data collection.</p></ack><ref-list><title>References</title><ref id="pone.0324366.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Grimm</surname><given-names>J</given-names></name>, <name><surname>Heckl</surname><given-names>D</given-names></name>, <name><surname>Klusmann</surname><given-names>J-H</given-names></name>. <article-title>Molecular mechanisms of the genetic predisposition to acute megakaryoblastic leukemia in infants with Down syndrome</article-title>. <source>Front Oncol</source>. <year>2021</year>;<volume>11</volume>:<fpage>636633</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fonc.2021.636633</pub-id>
<pub-id pub-id-type="pmid">33777792</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>S-Y</given-names></name>, <name><surname>Hsieh</surname><given-names>C-J</given-names></name>, <name><surname>Chen</surname><given-names>Y-L</given-names></name>, <name><surname>Shaw</surname><given-names>SWS</given-names></name>, <name><surname>Lin</surname><given-names>M-W</given-names></name>, <name><surname>Chen</surname><given-names>P-C</given-names></name>, <etal>et al</etal>. <article-title>The impact of Down syndrome screening on Taiwanese Down syndrome births: a nationwide retrospective study and a screening result from a single medical centre</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>9</issue>):e75428. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0075428</pub-id>
<pub-id pub-id-type="pmid">24147155</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Antonarakis</surname><given-names>SE</given-names></name>, <name><surname>Skotko</surname><given-names>BG</given-names></name>, <name><surname>Rafii</surname><given-names>MS</given-names></name>, <name><surname>Strydom</surname><given-names>A</given-names></name>, <name><surname>Pape</surname><given-names>SE</given-names></name>, <name><surname>Bianchi</surname><given-names>DW</given-names></name>, <etal>et al</etal>. <article-title>Down syndrome</article-title>. <source>Nat Rev Dis Primers</source>. <year>2020</year>;<volume>6</volume>(<issue>1</issue>):<fpage>9</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41572-019-0143-7</pub-id>
<pub-id pub-id-type="pmid">32029743</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Bull</surname><given-names>MJ</given-names></name>, <name><surname>Trotter</surname><given-names>T</given-names></name>, <name><surname>Santoro</surname><given-names>SL</given-names></name>, <name><surname>Christensen</surname><given-names>C</given-names></name>, <name><surname>Grout</surname><given-names>RW</given-names></name>, <collab>Council on Genetics</collab>, <etal>et al</etal>. <article-title>Health supervision for children and adolescents with Down syndrome</article-title>. <source>Pediatrics</source>. <year>2022</year>;<volume>149</volume>(<issue>5</issue>):e2022057010. <comment>doi: </comment><pub-id pub-id-type="doi">10.1542/peds.2022-057010</pub-id>
<pub-id pub-id-type="pmid">35490285</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Roizen</surname><given-names>NJ</given-names></name>, <name><surname>Mets</surname><given-names>MB</given-names></name>, <name><surname>Blondis</surname><given-names>TA</given-names></name>. <article-title>Ophthalmic disorders in children with Down syndrome</article-title>. <source>Dev Med Child Neurol</source>. <year>1994</year>;<volume>36</volume>(<issue>7</issue>):<fpage>594</fpage>&#x02013;<lpage>600</lpage>.<pub-id pub-id-type="pmid">8034121</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Caputo</surname><given-names>A</given-names></name>, <name><surname>Wagner</surname><given-names>R</given-names></name>, <name><surname>Reynolds</surname><given-names>D</given-names></name>, <name><surname>Guo</surname><given-names>S</given-names></name>, <name><surname>Goel</surname><given-names>A</given-names></name>. <article-title>Down syndrome clinical review of ocular features</article-title>. <source>Clin Pediatr (Phila)</source>. <year>1989</year>;<volume>28</volume>(<issue>8</issue>):<fpage>355</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">2527102</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Jaeger</surname><given-names>EA</given-names></name>. <article-title>Ocular findings in Down&#x02019;s syndrome</article-title>. <source>Trans Am Ophthalmol Soc</source>. <year>1980</year>;<volume>78</volume>:<fpage>808</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="pmid">6455003</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Watt</surname><given-names>T</given-names></name>, <name><surname>Robertson</surname><given-names>K</given-names></name>, <name><surname>Jacobs</surname><given-names>RJ</given-names></name>. <article-title>Refractive error, binocular vision and accommodation of children with Down syndrome</article-title>. <source>Clin Exp Optom</source>. <year>2015</year>;<volume>98</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02013;<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/cxo.12232</pub-id>
<pub-id pub-id-type="pmid">25395109</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Afifi</surname><given-names>HH</given-names></name>, <name><surname>Abdel Azeem</surname><given-names>AA</given-names></name>, <name><surname>El-Bassyouni</surname><given-names>HT</given-names></name>, <name><surname>Gheith</surname><given-names>ME</given-names></name>, <name><surname>Rizk</surname><given-names>A</given-names></name>, <name><surname>Bateman</surname><given-names>JB</given-names></name>. <article-title>Distinct ocular expression in infants and children with Down syndrome in Cairo, Egypt: myopia and heart disease</article-title>. <source>JAMA Ophthalmol</source>. <year>2013</year>;<volume>131</volume>(<issue>8</issue>):<fpage>1057</fpage>&#x02013;<lpage>66</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamaophthalmol.2013.644</pub-id>
<pub-id pub-id-type="pmid">23764677</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Ljubic</surname><given-names>A</given-names></name>, <name><surname>Trajkovski</surname><given-names>V</given-names></name>, <name><surname>Stankovic</surname><given-names>B</given-names></name>. <article-title>Strabismus, refractive errors and nystagmus in children and young adults with Down syndrome</article-title>. <source>Ophthalmic Genet</source>. <year>2011</year>;<volume>32</volume>(<issue>4</issue>):<fpage>204</fpage>&#x02013;<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3109/13816810.2011.592175</pub-id>
<pub-id pub-id-type="pmid">21728809</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Paudel</surname><given-names>N</given-names></name>, <name><surname>Leat</surname><given-names>SJ</given-names></name>, <name><surname>Adhikari</surname><given-names>P</given-names></name>, <name><surname>Woodhouse</surname><given-names>JM</given-names></name>, <name><surname>Shrestha</surname><given-names>JB</given-names></name>. <article-title>Visual defects in Nepalese children with Down syndrome</article-title>. <source>Clin Exp Optom</source>. <year>2010</year>;<volume>93</volume>(<issue>2</issue>):<fpage>83</fpage>&#x02013;<lpage>90</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1444-0938.2010.00458.x</pub-id>
<pub-id pub-id-type="pmid">20406257</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Liza-Sharmini</surname><given-names>AT</given-names></name>, <name><surname>Azlan</surname><given-names>ZN</given-names></name>, <name><surname>Zilfalil</surname><given-names>BA</given-names></name>. <article-title>Ocular findings in Malaysian children with Down syndrome</article-title>. <source>Singapore Med J</source>. <year>2006</year>;<volume>47</volume>(<issue>1</issue>):<fpage>14</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">16397715</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Creavin</surname><given-names>AL</given-names></name>, <name><surname>Brown</surname><given-names>RD</given-names></name>. <article-title>Ophthalmic assessment of children with down syndrome: is England doing its bit?</article-title>. <source>Strabismus</source>. <year>2010</year>;<volume>18</volume>(<issue>4</issue>):<fpage>142</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3109/09273972.2010.529232</pub-id>
<pub-id pub-id-type="pmid">21091335</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>de Weger</surname><given-names>C</given-names></name>, <name><surname>Boonstra</surname><given-names>N</given-names></name>, <name><surname>Goossens</surname><given-names>J</given-names></name>. <article-title>Bifocals reduce strabismus in children with Down syndrome: evidence from a randomized controlled trial</article-title>. <source>Acta Ophthalmol</source>. <year>2020</year>;<volume>98</volume>(<issue>1</issue>):<fpage>89</fpage>&#x02013;<lpage>97</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/aos.14186</pub-id>
<pub-id pub-id-type="pmid">31313886</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>da Cunha</surname><given-names>RP</given-names></name>, <name><surname>Moreira</surname><given-names>JB</given-names></name>. <article-title>Ocular findings in Down&#x02019;s syndrome</article-title>. <source>Am J Ophthalmol</source>. <year>1996</year>;<volume>122</volume>(<issue>2</issue>):<fpage>236</fpage>&#x02013;<lpage>44</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0002-9394(14)72015-x</pub-id>
<pub-id pub-id-type="pmid">8694092</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Wallace</surname><given-names>DK</given-names></name>, <name><surname>Morse</surname><given-names>CL</given-names></name>, <name><surname>Melia</surname><given-names>M</given-names></name>, <name><surname>Sprunger</surname><given-names>DT</given-names></name>, <name><surname>Repka</surname><given-names>MX</given-names></name>, <name><surname>Lee</surname><given-names>KA</given-names></name>, <etal>et al</etal>. <article-title>Pediatric eye evaluations preferred practice pattern&#x000ae;: I. Vision screening in the primary care and community setting; II. Comprehensive ophthalmic examination</article-title>. <source>Ophthalmology</source>. <year>2018</year>;<volume>125</volume>(<issue>1</issue>):P184&#x02013;<lpage>227</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ophtha.2017.09.032</pub-id>
<pub-id pub-id-type="pmid">29108745</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Donahue</surname><given-names>SP</given-names></name>, <name><surname>Arthur</surname><given-names>B</given-names></name>, <name><surname>Neely</surname><given-names>DE</given-names></name>, <name><surname>Arnold</surname><given-names>RW</given-names></name>, <name><surname>Silbert</surname><given-names>D</given-names></name>, <name><surname>Ruben</surname><given-names>JB</given-names></name>, <etal>et al</etal>. <article-title>Guidelines for automated preschool vision screening: a 10-year, evidence-based update</article-title>. <source>J AAPOS</source>. <year>2013</year>;<volume>17</volume>(<issue>1</issue>):<fpage>4</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jaapos.2012.09.012</pub-id>
<pub-id pub-id-type="pmid">23360915</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Fong</surname><given-names>AHC</given-names></name>, <name><surname>Shum</surname><given-names>J</given-names></name>, <name><surname>Ng</surname><given-names>ALK</given-names></name>, <name><surname>Li</surname><given-names>KKW</given-names></name>, <name><surname>McGhee</surname><given-names>S</given-names></name>, <name><surname>Wong</surname><given-names>D</given-names></name>. <article-title>Prevalence of ocular abnormalities in adults with Down syndrome in Hong Kong</article-title>. <source>Br J Ophthalmol</source>. <year>2013</year>;<volume>97</volume>(<issue>4</issue>):<fpage>423</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bjophthalmol-2012-302327</pub-id>
<pub-id pub-id-type="pmid">23376568</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Little</surname><given-names>J-A</given-names></name>, <name><surname>Mahil</surname><given-names>A-DS</given-names></name>, <name><surname>Richardson</surname><given-names>P</given-names></name>, <name><surname>Woodhouse</surname><given-names>JM</given-names></name>, <name><surname>Vinuela-Navarro</surname><given-names>V</given-names></name>, <name><surname>Saunders</surname><given-names>KJ</given-names></name>. <article-title>In-vivo anterior segment OCT imaging provides unique insight into cerulean blue-dot opacities and cataracts in Down syndrome</article-title>. <source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>):<fpage>10031</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/s41598-020-66642-1</pub-id>
<pub-id pub-id-type="pmid">32572106</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Ugurlu</surname><given-names>A</given-names></name>, <name><surname>Altinkurt</surname><given-names>E</given-names></name>. <article-title>Ophthalmologic manifestations and retinal findings in children with Down syndrome</article-title>. <source>J Ophthalmol</source>. <year>2020</year>;<volume>2020</volume>:<fpage>9726261</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1155/2020/9726261</pub-id>
<pub-id pub-id-type="pmid">32089873</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Makateb</surname><given-names>A</given-names></name>, <name><surname>Hashemi</surname><given-names>H</given-names></name>, <name><surname>Farahi</surname><given-names>A</given-names></name>, <name><surname>Mehravaran</surname><given-names>S</given-names></name>, <name><surname>Khabazkhoob</surname><given-names>M</given-names></name>, <name><surname>Asgari</surname><given-names>S</given-names></name>. <article-title>Ocular alignment, media, and eyelid disorders in Down syndrome</article-title>. <source>Strabismus</source>. <year>2020</year>;<volume>28</volume>(<issue>1</issue>):<fpage>42</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">31830843</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Umfress</surname><given-names>AC</given-names></name>, <name><surname>Hair</surname><given-names>CD</given-names></name>, <name><surname>Donahue</surname><given-names>SP</given-names></name>. <article-title>Prevalence of ocular pathology on initial screening and incidence of new findings on follow-up examinations in children with trisomy 21</article-title>. <source>Am J Ophthalmol</source>. <year>2019</year>;<volume>207</volume>:<fpage>373</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ajo.2019.06.006</pub-id>
<pub-id pub-id-type="pmid">31220432</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Purpura</surname><given-names>G</given-names></name>, <name><surname>Bacci</surname><given-names>GM</given-names></name>, <name><surname>Bargagna</surname><given-names>S</given-names></name>, <name><surname>Cioni</surname><given-names>G</given-names></name>, <name><surname>Caputo</surname><given-names>R</given-names></name>, <name><surname>Tinelli</surname><given-names>F</given-names></name>. <article-title>Visual assessment in Down Syndrome: the relevance of early visual functions</article-title>. <source>Early Hum Dev</source>. <year>2019</year>;<volume>131</volume>:<fpage>21</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.earlhumdev.2019.01.020</pub-id>
<pub-id pub-id-type="pmid">30818135</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Ljubic</surname><given-names>A</given-names></name>, <name><surname>Trajkovski</surname><given-names>V</given-names></name>, <name><surname>Tesic</surname><given-names>M</given-names></name>, <name><surname>Tojtovska</surname><given-names>B</given-names></name>, <name><surname>Stankovic</surname><given-names>B</given-names></name>. <article-title>Ophthalmic manifestations in children and young adults with Down syndrome and congenital heart defects</article-title>. <source>Ophthalmic Epidemiol</source>. <year>2015</year>;<volume>22</volume>(<issue>2</issue>):<fpage>123</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3109/09286586.2015.1017652</pub-id>
<pub-id pub-id-type="pmid">25777312</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Aghaji</surname><given-names>AE</given-names></name>, <name><surname>Lawrence</surname><given-names>L</given-names></name>, <name><surname>Ezegwui</surname><given-names>I</given-names></name>, <name><surname>Onwasigwe</surname><given-names>E</given-names></name>, <name><surname>Okoye</surname><given-names>O</given-names></name>, <name><surname>Ebigbo</surname><given-names>P</given-names></name>. <article-title>Unmet visual needs of children with Down syndrome in an African population: implications for visual and cognitive development</article-title>. <source>Eur J Ophthalmol</source>. <year>2013</year>;<volume>23</volume>(<issue>3</issue>):<fpage>394</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5301/ejo.5000222</pub-id>
<pub-id pub-id-type="pmid">23335310</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Han</surname><given-names>DH</given-names></name>, <name><surname>Kim</surname><given-names>KH</given-names></name>, <name><surname>Paik</surname><given-names>HJ</given-names></name>. <article-title>Refractive errors and strabismus in Down&#x02019;s syndrome in Korea</article-title>. <source>Korean J Ophthalmol</source>. <year>2012</year>;<volume>26</volume>(<issue>6</issue>):<fpage>451</fpage>&#x02013;<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3341/kjo.2012.26.6.451</pub-id>
<pub-id pub-id-type="pmid">23204801</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Adio</surname><given-names>AO</given-names></name>, <name><surname>Wajuihian</surname><given-names>SO</given-names></name>. <article-title>Ophthalmic manifestations of children with Down syndrome in Port Harcourt, Nigeria</article-title>. <source>Clin Ophthalmol</source>. <year>2012</year>;<volume>6</volume>:<fpage>1859</fpage>&#x02013;<lpage>64</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2147/OPTH.S36685</pub-id>
<pub-id pub-id-type="pmid">23185113</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>U</given-names></name>, <name><surname>Hwang</surname><given-names>J-M</given-names></name>. <article-title>Refractive errors and strabismus in Asian patients with Down syndrome</article-title>. <source>Eye (Lond)</source>. <year>2009</year>;<volume>23</volume>(<issue>7</issue>):<fpage>1560</fpage>&#x02013;<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/eye.2008.309</pub-id>
<pub-id pub-id-type="pmid">18849915</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Fimiani</surname><given-names>F</given-names></name>, <name><surname>Iovine</surname><given-names>A</given-names></name>, <name><surname>Carelli</surname><given-names>R</given-names></name>, <name><surname>Pansini</surname><given-names>M</given-names></name>, <name><surname>Sebastio</surname><given-names>G</given-names></name>, <name><surname>Magli</surname><given-names>A</given-names></name>. <article-title>Incidence of ocular pathologies in Italian children with Down syndrome</article-title>. <source>Eur J Ophthalmol</source>. <year>2007</year>;<volume>17</volume>(<issue>5</issue>):<fpage>817</fpage>&#x02013;<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/112067210701700521</pub-id>
<pub-id pub-id-type="pmid">17932861</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>JH</given-names></name>, <name><surname>Hwang</surname><given-names>J-M</given-names></name>, <name><surname>Kim</surname><given-names>HJ</given-names></name>, <name><surname>Yu</surname><given-names>YS</given-names></name>. <article-title>Characteristic ocular findings in Asian children with Down syndrome</article-title>. <source>Eye (Lond)</source>. <year>2002</year>;<volume>16</volume>(<issue>6</issue>):<fpage>710</fpage>&#x02013;<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/sj.eye.6700208</pub-id>
<pub-id pub-id-type="pmid">12439664</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Merrick</surname><given-names>J</given-names></name>, <name><surname>Koslowe</surname><given-names>K</given-names></name>. <article-title>Refractive errors and visual anomalies in Down syndrome</article-title>. <source>Downs Syndr Res Pract</source>. <year>2001</year>;<volume>6</volume>(<issue>3</issue>):<fpage>131</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">11501216</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Wong</surname><given-names>V</given-names></name>, <name><surname>Ho</surname><given-names>D</given-names></name>. <article-title>Ocular abnormalities in Down syndrome: an analysis of 140 Chinese children</article-title>. <source>Pediatr Neurol</source>. <year>1997</year>;<volume>16</volume>(<issue>4</issue>):<fpage>311</fpage>&#x02013;<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0887-8994(97)00029-5</pub-id>
<pub-id pub-id-type="pmid">9258964</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Berk</surname><given-names>AT</given-names></name>, <name><surname>Saatci</surname><given-names>AO</given-names></name>, <name><surname>Er&#x000e7;al</surname><given-names>MD</given-names></name>, <name><surname>Tun&#x000e7;</surname><given-names>M</given-names></name>, <name><surname>Ergin</surname><given-names>M</given-names></name>. <article-title>Ocular findings in 55 patients with Down&#x02019;s syndrome</article-title>. <source>Ophthalmic Genet</source>. <year>1996</year>;<volume>17</volume>(<issue>1</issue>):<fpage>15</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3109/13816819609057864</pub-id>
<pub-id pub-id-type="pmid">8740693</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Akinci</surname><given-names>A</given-names></name>, <name><surname>Oner</surname><given-names>O</given-names></name>, <name><surname>Bozkurt</surname><given-names>OH</given-names></name>, <name><surname>Guven</surname><given-names>A</given-names></name>, <name><surname>Degerliyurt</surname><given-names>A</given-names></name>, <name><surname>Munir</surname><given-names>K</given-names></name>. <article-title>Refractive errors and strabismus in children with Ddown syndrome: a controlled study</article-title>. <source>J Pediatr Ophthalmol Strabismus</source>. <year>2009</year>;<volume>46</volume>(<issue>2</issue>):<fpage>83</fpage>&#x02013;<lpage>6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3928/01913913-20090301-04</pub-id>
<pub-id pub-id-type="pmid">19343969</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Haugen</surname><given-names>OH</given-names></name>, <name><surname>H&#x000f8;vding</surname><given-names>G</given-names></name>, <name><surname>Lundstr&#x000f6;m</surname><given-names>I</given-names></name>. <article-title>Refractive development in children with Down&#x02019;s syndrome: a population based, longitudinal study</article-title>. <source>Br J Ophthalmol</source>. <year>2001</year>;<volume>85</volume>(<issue>6</issue>):<fpage>714</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bjo.85.6.714</pub-id>
<pub-id pub-id-type="pmid">11371494</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Donovan</surname><given-names>L</given-names></name>, <name><surname>Sankaridurg</surname><given-names>P</given-names></name>, <name><surname>Ho</surname><given-names>A</given-names></name>, <name><surname>Naduvilath</surname><given-names>T</given-names></name>, <name><surname>Smith</surname><given-names>E</given-names><suffix>3rd</suffix></name>, <name><surname>Holden</surname><given-names>B</given-names></name>. <article-title>Myopia progression rates in urban children wearing single-vision spectacles</article-title>. <source>Optom Vis Sci</source>. <year>2012</year>;<volume>89</volume>(<issue>1</issue>):<fpage>27</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">21983120</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Tsai</surname><given-names>T-H</given-names></name>, <name><surname>Liu</surname><given-names>Y-L</given-names></name>, <name><surname>Ma</surname><given-names>I-H</given-names></name>, <name><surname>Su</surname><given-names>C-C</given-names></name>, <name><surname>Lin</surname><given-names>C-W</given-names></name>, <name><surname>Lin</surname><given-names>LL-K</given-names></name>, <etal>et al</etal>. <article-title>Evolution of the prevalence of myopia among Taiwanese school children: a review of survey data from 1983 through 2017</article-title>. <source>Ophthalmology</source>. <year>2021</year>;<volume>128</volume>(<issue>2</issue>):<fpage>290</fpage>&#x02013;<lpage>301</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ophtha.2020.07.017</pub-id>
<pub-id pub-id-type="pmid">32679159</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>Z</given-names></name>, <name><surname>Gu</surname><given-names>D</given-names></name>, <name><surname>Wang</surname><given-names>B</given-names></name>, <name><surname>Kang</surname><given-names>P</given-names></name>, <name><surname>Watt</surname><given-names>K</given-names></name>, <name><surname>Yang</surname><given-names>Z</given-names></name>. <article-title>Significant myopic shift over time: sixteen-year trends in overall refraction and age of myopia onset among Chinese children, with a focus on ages 4&#x02013;6 years</article-title>. <source>J Glob Health</source>. <year>2023</year>;<volume>13</volume>:<fpage>04144</fpage>.<pub-id pub-id-type="pmid">37934967</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Cregg</surname><given-names>M</given-names></name>, <name><surname>Woodhouse</surname><given-names>JM</given-names></name>, <name><surname>Stewart</surname><given-names>RE</given-names></name>, <name><surname>Pakeman</surname><given-names>VH</given-names></name>, <name><surname>Bromham</surname><given-names>NR</given-names></name>, <name><surname>Gunter</surname><given-names>HL</given-names></name>, <etal>et al</etal>. <article-title>Development of refractive error and strabismus in children with Down syndrome</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>2003</year>;<volume>44</volume>(<issue>3</issue>):<fpage>1023</fpage>&#x02013;<lpage>30</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1167/iovs.01-0131</pub-id>
<pub-id pub-id-type="pmid">12601024</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Fan</surname><given-names>DSP</given-names></name>, <name><surname>Rao</surname><given-names>SK</given-names></name>, <name><surname>Cheung</surname><given-names>EYY</given-names></name>, <name><surname>Islam</surname><given-names>M</given-names></name>, <name><surname>Chew</surname><given-names>S</given-names></name>, <name><surname>Lam</surname><given-names>DSC</given-names></name>. <article-title>Astigmatism in Chinese preschool children: prevalence, change, and effect on refractive development</article-title>. <source>Br J Ophthalmol</source>. <year>2004</year>;<volume>88</volume>(<issue>7</issue>):<fpage>938</fpage>&#x02013;<lpage>41</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bjo.2003.030338</pub-id>
<pub-id pub-id-type="pmid">15205242</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Castagno</surname><given-names>VD</given-names></name>, <name><surname>Fassa</surname><given-names>AG</given-names></name>, <name><surname>Carret</surname><given-names>MLV</given-names></name>, <name><surname>Vilela</surname><given-names>MAP</given-names></name>, <name><surname>Meucci</surname><given-names>RD</given-names></name>. <article-title>Hyperopia: a meta-analysis of prevalence and a review of associated factors among school-aged children</article-title>. <source>BMC Ophthalmol</source>. <year>2014</year>;<volume>14</volume>:<fpage>163</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/1471-2415-14-163</pub-id>
<pub-id pub-id-type="pmid">25539893</pub-id>
</mixed-citation></ref><ref id="pone.0324366.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Cho</surname><given-names>YA</given-names></name>, <name><surname>Ryu</surname><given-names>WY</given-names></name>. <article-title>Changes in refractive error in patients with accommodative esotropia after being weaned from hyperopic correction</article-title>. <source>Br J Ophthalmol</source>. <year>2015</year>;<volume>99</volume>(<issue>5</issue>):<fpage>680</fpage>&#x02013;<lpage>4</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bjophthalmol-2014-305991</pub-id>
<pub-id pub-id-type="pmid">25416183</pub-id>
</mixed-citation></ref></ref-list></back></article>